BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burisch J, Weimers P, Pedersen N, Cukovic-Cavka S, Vucelic B, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I. Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study. J Crohns Colitis. 2014;8:1030-1042. [PMID: 24560877 DOI: 10.1016/j.crohns.2014.01.028] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Borren NZ, Tan W, Colizzo FP, Luther J, Garber JJ, Khalili H, van Der Woude CJ, Ananthakrishnan AN. Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study. Journal of Crohn's and Colitis 2020;14:309-15. [DOI: 10.1093/ecco-jcc/jjz148] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
2 Ankersen DV, Weimers P, Marker D, Bennedsen M, Saboori S, Paridaens K, Burisch J, Munkholm P. Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: A randomized-clinical trial. World J Gastroenterol 2019;25:6158-71. [PMID: 31686770 DOI: 10.3748/wjg.v25.i40.6158] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
3 Larussa T, Flauti D, Abenavoli L, Boccuto L, Suraci E, Marasco R, Imeneo M, Luzza F. The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study. J Clin Med 2020;9:E2416. [PMID: 32731482 DOI: 10.3390/jcm9082416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Goren G, Schwartz D, Friger M, Banai H, Sergienko R, Regev S, Abu-Kaf H, Greenberg D, Nemirovsky A, Ilan K, Lerner L, Monsonego A, Dotan I, Yanai H, Eliakim R, Ben Horin S, Slonim-Nevo V, Odes S, Sarid O. Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease. Inflamm Bowel Dis 2021:izab083. [PMID: 33847758 DOI: 10.1093/ibd/izab083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 D'Amico F, Baumann C, Rousseau H, Danese S, Peyrin-Biroulet L. Phase I, II and III Trials in Inflammatory Bowel Diseases: A Practical Guide for the Non-specialist. J Crohns Colitis 2020;14:710-8. [PMID: 31901097 DOI: 10.1093/ecco-jcc/jjz214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Burisch J, Vardi H, Pedersen N, Brinar M, Cukovic-cavka S, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Bailey Y, Oʼmorain C, Schwartz D, Lupinacci G, De Padova A, Jonaitis L, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Pineda JR, Almer S, Halfvarson J, Tsai H, Sebastian S, Friger M, Greenberg D, Lakatos PL, Langholz E, Odes S, Munkholm P. Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort: An ECCO-EpiCom Study. Inflammatory Bowel Diseases 2015;21:121-31. [DOI: 10.1097/mib.0000000000000250] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
7 Bączyk G, Formanowicz D, Gmerek Ł, Krokowicz P. Health-related quality of life assessment among patients with inflammatory bowel diseases after surgery - review. Prz Gastroenterol 2017;12:6-16. [PMID: 28337230 DOI: 10.5114/pg.2016.64037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
8 Maagaard L, Ankersen DV, Végh Z, Burisch J, Jensen L, Pedersen N, Munkholm P. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol 2016;22:4009-19. [PMID: 27099444 DOI: 10.3748/wjg.v22.i15.4009] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 57] [Article Influence: 18.0] [Reference Citation Analysis]
9 Larussa T, Suraci E, Marasco R, Imeneo M, Dumitrascu DL, Abenavoli L, Luzza F. Barriers and Facilitators in Conducting Clinical Trials in Inflammatory Bowel Disease: A Monocentric Italian Survey. Rev Recent Clin Trials 2020;15:137-44. [PMID: 32091346 DOI: 10.2174/1574887115666200224113520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Hagelund LM, Elkjær Stallknecht S, Jensen HH. Quality of life and patient preferences among Danish patients with ulcerative colitis - results from a survey study. Curr Med Res Opin 2020;36:771-9. [PMID: 31944145 DOI: 10.1080/03007995.2020.1716704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Min Ho PY, Hu W, Lee YY, Gao C, Tan YZ, Cheen HH, Wee HL, Lim TG, Ong WC. Health-related quality of life of patients with inflammatory bowel disease in Singapore. Intest Res 2019;17:107-18. [PMID: 30419638 DOI: 10.5217/ir.2018.00099] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
12 Slonim-Nevo V, Sarid O, Friger M, Schwartz D, Chernin E, Shahar I, Sergienko R, Vardi H, Rosenthal A, Mushkalo A, Dizengof V, Ben-Yakov G, Abu-Freha N, Munteanu D, Gaspar N, Eidelman L, Segal A, Fich A, Greenberg D, Odes S; Israeli IBD Research Nucleus (IIRN). Effect of psychosocial stressors on patients with Crohn's disease: threatening life experiences and family relations. Eur J Gastroenterol Hepatol. 2016;28:1073-1081. [PMID: 27203602 DOI: 10.1097/meg.0000000000000666] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
13 Odes S, Friger M, Sergienko R, Schwartz D, Sarid O, Slonim-Nevo V, Singer T, Chernin E, Vardi H, Greenberg D, Israel Ibd Research Nucleus. Simple pain measures reveal psycho-social pathology in patients with Crohn's disease. World J Gastroenterol 2017;23:1076-89. [PMID: 28246482 DOI: 10.3748/wjg.v23.i6.1076] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
14 Peyrin-biroulet L, Sandborn W, Sands BE, Reinisch W, Bemelman W, Bryant RV, D'haens G, Dotan I, Dubinsky M, Feagan B, Fiorino G, Gearry R, Krishnareddy S, Lakatos PL, Loftus EV, Marteau P, Munkholm P, Murdoch TB, Ordás I, Panaccione R, Riddell RH, Ruel J, Rubin DT, Samaan M, Siegel CA, Silverberg MS, Stoker J, Schreiber S, Travis S, Van Assche G, Danese S, Panes J, Bouguen G, O'donnell S, Pariente B, Winer S, Hanauer S, Colombel J-. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. American Journal of Gastroenterology 2015;110:1324-38. [DOI: 10.1038/ajg.2015.233] [Cited by in Crossref: 937] [Cited by in F6Publishing: 752] [Article Influence: 156.2] [Reference Citation Analysis]
15 Sarid O, Slonim-Nevo V, Pereg A, Friger M, Sergienko R, Schwartz D, Greenberg D, Shahar I, Chernin E, Vardi H, Eidelman L, Segal A, Ben-Yakov G, Gaspar N, Munteanu D, Rozental A, Mushkalo A, Dizengof V, Abu-Freha N, Fich A, Odes S; Israeli IBD Research Nucleus (IIRN). Coping strategies, satisfaction with life, and quality of life in Crohn's disease: A gender perspective using structural equation modeling analysis. PLoS One 2017;12:e0172779. [PMID: 28245260 DOI: 10.1371/journal.pone.0172779] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
16 Fumery M, Singh S, Dulai PS, Gower-Rousseau C, Peyrin-Biroulet L, Sandborn WJ. Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol. 2018;16:343-356.e3. [PMID: 28625817 DOI: 10.1016/j.cgh.2017.06.016] [Cited by in Crossref: 116] [Cited by in F6Publishing: 88] [Article Influence: 29.0] [Reference Citation Analysis]
17 Van Assche G, Peyrin-Biroulet L, Sturm A, Gisbert JP, Gaya DR, Bokemeyer B, Mantzaris GJ, Armuzzi A, Sebastian S, Lara N, Lynam M, Rojas-Farreras S, Fan T, Ding Q, Black CM, Kachroo S. Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study. Dig Liver Dis. 2016;48:592-600. [PMID: 26935454 DOI: 10.1016/j.dld.2016.01.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
18 Sandborn WJ, Ghosh S, Panes J, Schreiber S, D'Haens G, Tanida S, Siffledeen J, Enejosa J, Zhou W, Othman AA, Huang B, Higgins PDR. Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis. Gastroenterology 2020;158:2139-2149.e14. [PMID: 32092309 DOI: 10.1053/j.gastro.2020.02.030] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 35.0] [Reference Citation Analysis]
19 Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II. Inflamm Bowel Dis. 2018;24:966-976. [PMID: 29688466 DOI: 10.1093/ibd/izy015] [Cited by in Crossref: 51] [Cited by in F6Publishing: 34] [Article Influence: 25.5] [Reference Citation Analysis]
20 Christiansen LK, Lo B, Bendtsen F, Vind I, Vester-Andersen MK, Burisch J. Health-related quality of life in inflammatory bowel disease in a Danish population-based inception cohort. United European Gastroenterol J 2019;7:942-54. [PMID: 31428419 DOI: 10.1177/2050640619852532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 McDermott E, Healy G, Mullen G, Keegan D, Byrne K, Guerandel A, Forry M, Moloney J, Doherty G, Cullen G, Malone K, Mulcahy H. Patient Education in Inflammatory Bowel Disease: A Patient-Centred, Mixed Methodology Study. J Crohns Colitis 2018;12:419-24. [PMID: 29293956 DOI: 10.1093/ecco-jcc/jjx175] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
22 Pedersen N, Thielsen P, Martinsen L, Bennedsen M, Haaber A, Langholz E, Végh Z, Duricova D, Jess T, Bell S, Burisch J, Munkholm P. eHealth: Individualization of Mesalazine Treatment Through a Self-managed Web-based Solution in Mild-to-moderate Ulcerative Colitis. Inflammatory Bowel Diseases 2014;20:2276-85. [DOI: 10.1097/mib.0000000000000199] [Cited by in Crossref: 54] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
23 Liu R, Tang A, Wang X, Shen S. Assessment of Quality of Life in Chinese Patients With Inflammatory Bowel Disease and their Caregivers. Inflamm Bowel Dis 2018;24:2039-47. [PMID: 29788383 DOI: 10.1093/ibd/izy099] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
24 White JR, Jairath V, Moran GW. Evolution of treatment targets in Crohn's disease. Best Pract Res Clin Gastroenterol 2019;38-39:101599. [PMID: 31327410 DOI: 10.1016/j.bpg.2019.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]